The PE ratio for LivaNova stock stands at 168.94 as of Apr 30, 2024. This is based on the current EPS of $0.33 and the stock price of $55.75 per share.
Year | PE ratio | Change |
---|---|---|
2023 | 156.79 | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
LIVN LivaNova PLC | 189.76 | $3.38B |
NVRO Nevro Corp | N/A | $378.9M |
OFIX Orthofix Medical Inc | N/A | $487.22M |
NURO NeuroMetrix Inc | N/A | $8.82M |
LIVN's price to earnings ratio is 168.94 as of Apr 30, 2024.
LIVN's PE ratio of 168.94 is considered high because the company's stock price is trading at a higher multiple of earnings.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 30, 2024), LivaNova's stock price is $55.75. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $0.33. Therefore, LivaNova's P/E ratio for today is 168.94. PE RATIO(168.94) = STOCK PRICE($55.75) / TTM EPS($0.33)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.